Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatment.
about
Coagulation, inflammation and myocardial dysfunction in unstable coronary artery disease and the influence of glycoprotein IIb/IIIa inhibition and low molecular weight heparinFirst experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.An Academic ECG Core Lab Perspective of the FDA Initiative for Digital ECG Capture and Data Management in Large-Scale Clinical Trials
P2860
Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatment.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Continuous multilead ST-monito ...... nded antithrombotic treatment.
@en
Continuous multilead ST-monito ...... nded antithrombotic treatment.
@nl
type
label
Continuous multilead ST-monito ...... nded antithrombotic treatment.
@en
Continuous multilead ST-monito ...... nded antithrombotic treatment.
@nl
prefLabel
Continuous multilead ST-monito ...... nded antithrombotic treatment.
@en
Continuous multilead ST-monito ...... nded antithrombotic treatment.
@nl
P2093
P356
P1476
Continuous multilead ST-monito ...... nded antithrombotic treatment.
@en
P2093
Abrahamsson P
Dellborg M
Jernberg T
Johanson P
Wallentin L
P304
P356
10.1053/EUHJ.2001.3043
P577
2002-07-01T00:00:00Z